Skip to main content

Dr. Dr. Barij Nayan Sinha Nayan Sinha Ph.D. M. Pharm. in Pharmaceutical Chemistry B. Pharm. B. Sc.

Date of Joining: 19th September, 1983
  • Quarter No: BSP-I/2, Birla Institute of Technology Campus Mesra, Ranchi - 835215 Jharkhand
  • 0651 2276247
    |
    0651 2276247

Research Areas

  • Drug Discovery Approaches with regard to Synthetic and Natural Leads using Modern Analytical Techniques and Softwares with special reference to Antiviral and Anticancer agents on different targets
  • Teaching & Learning-Pedagogical Concepts

Work Experience

  • Teaching: 37 Years
  • Research: 36 Years


<!-- THEME DEBUG -->
<!-- THEME HOOK: 'field' -->
<!-- FILE NAME SUGGESTIONS:
   ▪️ field--node--title--faculty.html.twig
   ✅ field--node--title.html.twig
   ▪️ field--node--faculty.html.twig
   ▪️ field--title.html.twig
   ▪️ field--string.html.twig
   ▪️ field.html.twig
-->
<!-- BEGIN OUTPUT from 'themes/contrib/bootstrap_barrio/templates/field/field--node--title.html.twig' -->
<span class=Dr. Barij Nayan Sinha " width="406" height="371" loading="lazy" >

Academic Profile

Award and Honours
Award and Honours

31

Total Award and Honours
Project
Project

5

Total Project

Leadership & Institutional Service

Teaching & Mentorship

Award and Honours

Índian Pharm. Association   Fellow'2016 was awarded at 68th IPC, Visakhapatnam( Dec.2016)

Coordinator-Pharma Alumni Networking Meet at BIT Mesra (Aug. 2016)

Chairperson- National Level Symposium on Antiviral Research & Therapy(NLSART'2016)

Current Sponsored Projects

  • DST-SERB sponsored : Design and Synthesis of Substrate Based Peptide Inhibitors of DEN V Protease for the Treatment of Dengue Viral Infections
  • Indo-German: DBT-BMBF sponsored : Structure-based design of Dengue virus protease inhibitors
  • Indo-UK: UGC-UKIERI sponsored- Design and synthesis of potent dual inhibitors of Cdk4 and tubulin as anticancer agent
  • ICAR-NAIP sponsored : To understand the nature of diversity in lac insects of Kerri asps In India and the nature of insect and host interaction

Intellectual Property Rights (IPR)

  • Arylmethylidine Heterocyclics as Novel Chikungunya viral infection inhibitors” (855/KOL/2013 A)

    • Date:
  • A stable antioxidant herbal composition comprising microspheres of Lagenaria siceraria fruit extract Process for preparing the same and use thereof (1690/MUM/2012)

    • Date:
  • 2-(4,6-Diaminopyrimidin-2-ylthiol)-N-arylacetamide derivatives, their synthesis, antiviral activity and methods thereof (325/KOL/2014)

    • Date:
  • 4-(1,3-Dioxoisoindolin-2-yl)-benzenesulfonamide derivatives, their synthesis, antiviral activity and methods there of (191/KOL/2014)

    • Date:

Fellowship

  1. Fellow of Institution of Chemist
  2. Fellow of Indian Pharmaceutical Association